LTA4H:Zn2+ hydrolyses 17R(16)-epoxy-DHA to AT-(N)PD1

Stable Identifier
R-HSA-9020257
Type
Reaction [transition]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Leukotriene A4 hydrolase (LTA4H) is a monomeric, soluble enzyme that uses a Zn2+ cofactor to catalyse the hydrolysis of the allylic epoxide leukotriene A4 (LTA4) (McGee & Fitzpatrick 1985). LTA4H may also be able to catalyse the hydrolysis of 17R(6)-epoxy-docosahexaenoic acid (17R(16)-epoxy-DHA) to 10(R),17(R)-dihydroxydocosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid (aspirin-triggered (neuro)protectin D1, AT-(N)PD1) (Serhan et al. 2011). In human cells, AT-(N)PD1 decreased PMN migration as well as enhancing efferocytosis of apoptotic human PMN by macrophages, indicating AT-(N)PD1 as a potent anti-inflammatory proresolving molecule (Serhan et al. 2011).
Literature References
PubMed ID Title Journal Year
21867913 Novel proresolving aspirin-triggered DHA pathway

Zhu, M, Serhan, CN, Winkler, JW, Petasis, NA, Bazan, NG, Fredman, G, Karamnov, S, Yang, R, Belayev, LS

Chem. Biol. 2011
Participants
Participates
Catalyst Activity

epoxide hydrolase activity of LTA4H:Zn2+ [cytosol]

Orthologous Events
Authored
Reviewed
Created
Cite Us!